Andas 5 Holding

Andas 5 Holding is a Swedish medical technology company focused on improving the management of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). The company's primary offering is a digital health platform and handheld device designed to monitor airway inflammation through the measurement of fractional exhaled nitric oxide (FeNO). By providing patients and clinicians with real-time data on lung inflammation, Andas 5 aims to enable more personalized treatment adjustments and better disease control. The company operates primarily within the Scandinavian market with a focus on integrating digital monitoring into standard respiratory care.